Press Releases

29 September 2014
Karus Therapeutics presenting at NCRI Cancer Conference

Stephen Shuttleworth, CSO of Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, will be attending and presenting two posters at the 10th NCRI Cancer Conference, 2-5 November 2014 in Liverpool. 

For more information on Karus’s presentations or for media enquiries, please contact karus@instinctif.com.